Involvement of GABAergic and glutamatergic systems in the anticonvulsant activity of 3-alkynyl selenophene in 21 day-old rats

Molecular and Cellular Biochemistry

Volumn 365, Issue 1-2, 2012, Pages 175-180

  Wilhelm, Ethel Antunes ^a   Gai, Bibiana Mozzaquatro ^a   Souza, Ana Cristina Guerra ^a   Bortolatto, Cristiani Folharini ^a   Roehrs, Juliano Alex ^a   Nogueira, Cristina Wayne ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Aminobutyric acid; Anticonvulsant; Glutamate; Pilocarpine; Selenium; Selenophene

Indexed keywords

2,4 DIAMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID; AMINOOXYACETIC ACID; ANTICONVULSIVE AGENT; GLUTAMIC ACID; MITOCHONDRIAL ENZYME; PILOCARPINE; SELENIUM DERIVATIVE; SELENOPHENE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN SLICE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; EPILEPSY; HIPPOCAMPUS; ISOTOPE LABELING; MALE; NEUROTRANSMISSION; NEWBORN; NONHUMAN; RAT; SEIZURE; SINGLE DRUG DOSE;

ANIMALS; ANTICONVULSANTS; CEREBRAL CORTEX; EXCITATORY AMINO ACID AGONISTS; GABAERGIC NEURONS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HIPPOCAMPUS; MALE; ORGANOSELENIUM COMPOUNDS; PILOCARPINE; RATS; RATS, WISTAR; SEIZURES;

ANIMALIA; RATTUS;

EID: 84860262573     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1257-3     Document Type: Article

References (35)

1. WA Hauser 1994 The prevalence and incidence of convulsive disorders in children Epilepsia 35 1 6 10.1111/j.1528-1157.1994.tb05932.x
2. IE Holopainen 2008 Seizures in the developing brain: cellular and molecular mechanisms of neuronal damage, neurogenesis and cellular reorganization Neurochem Int 52 935 947 18093696 10.1016/j.neuint.2007.10.021 1:CAS:528:DC%2BD1cXktVKltb0%3D
3. S Ozawa H Kamiya K Tsukuki 1998 Glutamate receptors in the mammalian central nervous system Prog Neurobiol 54 581 618 9550192 10.1016/S0301-0082(97) 00085-3 1:CAS:528:DyaK1cXitlymt7w%3D
4. NJ Maragakis JD Rothstein 2004 Glutamate transporters: animal models to neurologic disease Neurobiol Dis 15 461 473 15056453 10.1016/j.nbd.2003.12.007 1:CAS:528:DC%2BD2cXivVKnu74%3D
5. SJ Czuczwar PN Patsalos 2001 The new generation of GABA enhancers. Potential in the treatment of epilepsy CNS Drugs 15 339 350 11475940 10.2165/00023210-200115050-00001 1:CAS:528:DC%2BD3MXkt1Ols7Y%3D
6. HS White 1999 Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs Epilepsia 40 S2 S10 10530688 10.1111/j.1528-1157.1999.tb00913.x 1:CAS:528:DyaK1MXntFynsbg%3D
7. A receptor function and pharmacology in epilepsy and status epilepticus Curr Opin Pharmacol 3 12 18 12550736 10.1016/S1471-4892(02)00015-2 1:CAS:528:DC%2BD3sXmsVartw%3D%3D
8. P Czapinski B Blaszczyk SJ Czuczwar 2005 Mechanisms of action of antiepileptic drugs Curr Top Med Chem 5 3 14 15638774 10.2174/1568026053386962 1:CAS:528:DC%2BD2MXpsFOgsg%3D%3D
9. HL Rowley KF Martin CA Marsden 1995 Decreased GABA release following tonic-clonic seizures is associated with an increase in extracellular glutamate in rat hippocampus in vivo Neuroscience 68 415 422 7477952 10.1016/0306-4522(95) 00159-G 1:CAS:528:DyaK2MXntF2jsb4%3D
10. MB Robinson LA Dowd 1997 Heterogeneity and functional subtypes of sodium-dependent glutamate transporters in the mammalian central nervous system Adv Pharmacol 37 69 115 8891100 10.1016/S1054-3589(08)60948-5 1:CAS:528:DyaK2sXivVOhsA%3D%3D
11. NC Danbolt 1994 The high affinity uptake system for excitatory amino acids in the brain Progr Neurobiol 44 377 396 10.1016/0301-0082(94)90033-7 1:CAS:528:DyaK2MXis1CqtLk%3D
12. EA Wilhelm CR Jesse CF Bortolatto CW Nogueira L Savegnago 2009 Antinociceptive and anti-allodynic effects of 3-alkynyl selenophene on different models of nociception in mice Pharmacol Biochem Behav 93 419 425 19538987 10.1016/j.pbb.2009.06.003 1:CAS:528:DC%2BD1MXpt1Kqsr4%3D
13. EA Wilhelm CR Jesse CF Bortolatto CW Nogueira L Savegnago 2009 Anticonvulsant and antioxidant effects of 3-alkynyl selenophene in 21-day-old rats on pilocarpine model of seizures Brain Res Bull 79 281 287 19480988 10.1016/j.brainresbull.2009.03.006 1:CAS:528:DC%2BD1MXms1Wmt7Y%3D
14. EA Wilhelm CR Jesse M Prigol D Alves RF Schumacher CW Nogueira 2010 3-Alkynyl selenophene protects against carbon-tetrachloride-induced and 2-nitropropane-induced hepatic damage in rats Cell Biol Toxicol 26 569 577 20397041 10.1007/s10565-010-9164-4 1:CAS:528:DC%2BC3cXhtlWksbrI
15. Alves D, Reis JS, Luchese C, Nogueira CW, Zeni G (2008) Synthesis of 3-alkynylselenophene derivatives by a cooper-free sonogashira cross-coupling reaction. Eur J Org Chem 2:377-382
16. ID Schweigert DL de Oliveira F Scheibel F da Costa ST Wofchuk DO Souza MLS Perry 2005 Gestational and postnatal malnutrition affects sensitivity of young rats to picrotoxin and quinolinic acid and uptake of GABA by cortical and hippocampal slices Dev Brain Res 154 177 185 10.1016/j.devbrainres.2004.10.013 1:CAS:528:DC%2BD2MXhtFOnur8%3D
17. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding Anal Biochem 72 248 254 942051 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D
18. GJ Amabeoku 1999 Gamma-aminobutyric acid and glutamic acid receptors may mediate theophylline-induced seizures in mice Gen Pharmacol 32 365 372 10211593 10.1016/S0306-3623(98)00201-8 1:CAS:528:DyaK1MXjtVGmuro%3D
19. DM Treiman 2001 GABAergic mechanisms in epilepsy Epilepsia 42 8 12 11520315 10.1046/j.1528-1157.2001.042suppl.3008.x
20. B Lippert BW Metcalf MJ Jung P Casara 1977 4-Aminohex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain Eur J Biochem 74 441 445 856582 10.1111/j.1432-1033.1977. tb11410.x 1:CAS:528:DyaE2sXktVWlu7o%3D
21. EA Swinyard HS White HH Wolf WE Bondinell 1991 Anticonvulsant profiles of the potent and orally active GABA uptake inhibitors SK&F 89976-A and SK&F 100330-A and four prototype antiepileptic drugs in mice and rats Eur J Pharmacol 236 147 149
22. M Prigol CA Brüning B Godoi CW Nogueira G Zeni 2009 m-Trifluoromethyl-diphenyl diselenide attenuates pentylenetetrazole-induced seizures in mice by inhibiting GABA uptake in cerebral cortex slices Pharmacol Rep 61 1127 1133 20081248 1:CAS:528:DC%2BC3cXos1Ggtb4%3D
23. YH Raol DR Lynch AR Brooks-Kayal 2001 Role of excitatory aminoacids in developmental epilepsies Ment Retard Dev Disabil Res Rev 7 254 260 11754519 10.1002/mrdd.1035 1:STN:280:DC%2BD38%2FgtVKntw%3D%3D
24. PM Beart RD O'Shea 2007 Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement Br J Pharmacol 150 5 17 17088867 10.1038/sj.bjp.0706949 1:CAS:528:DC%2BD2sXis1Kisw%3D%3D
25. JJ Asconapé 2010 The selection of antiepileptic drugs for the treatment of epilepsy in children and adults Neurol Clin 28 843 852 20816265 10.1016/j.ncl.2010.03.026
26. S Shorvon 2011 The treatment of status epilepticus Curr Opin Neurol 24 165 170 21378567 10.1097/WCO.0b013e3283446f31 1:CAS:528:DC%2BC3MXivVGitLc%3D
27. JJ Luszczki SJ Czuczwasr 2004 Preclinical profile of combinations of some second-geration antiepileptic drugs: an isobolographic analysis Epilepsia 45 895 907 15270754 10.1111/j.0013-9580.2004.05104.x 1:CAS:528:DC%2BD2cXosVWisLg%3D
28. JD Wood SJ Peesker 1973 The role of GABA metabolism in the convulsant and anticonvulsant actions of aminooxyacetic acid J Neurochem 20 379 387 4698285 10.1111/j.1471-4159.1973.tb12137.x 1:CAS:528:DyaE3sXhtF2nsLc%3D
29. U Sonnewald TM Kortner H Qu E Olstad C Suñol LK Bak A Schousboe HS Waagepetersen 2006 Demonstration of extensive GABA synthesis in the small population of GAD positive neurons in cerebellar cultures by the use of pharmacological tools Neurochem Int 48 572 578 16516347 10.1016/j.neuint.2006. 01.005 1:CAS:528:DC%2BD28XjtFCrtrY%3D
30. FM Sherif SS Ahmed 1995 Basic aspects of GABA-transaminase in neuropsychiatric disorders Clin Biochem 28 145 154 7628073 10.1016/0009-9120(94) 00074-6 1:CAS:528:DyaK2MXmt1eqsrw%3D
31. GJ Sills 2003 Pre-clinical studies with the GABAergic compounds vigabatrin and tiagabine Epileptic Disord 5 51 56 12773297
32. P Krogsgaard-Larsen B Frolund K Frydenvang 2000 GABA uptake inhibitors. Design, molecular pharmacology and therapeutic aspects Curr Pharm Des 6 1193 1209 10903390 10.2174/1381612003399608 1:CAS:528:DC%2BD3cXlsFygtLo%3D
33. EN Maciel EMM Flores JBT Rocha V Folmer 2003 Comparative deposition of diphenyl diselenide in liver, kidney, and brain of mice Bull Environ Contam Toxicol 70 470 476 12592520 10.1007/s00128-003-0010-8 1:CAS:528: DC%2BD3sXitFGmsb4%3D
34. M Prigol RF Schumacher CW Nogueira G Zeni 2009 Convulsant effect of diphenyl diselenide in rats and mice and its relationship to plasma levels Toxicol Lett 189 35 39 19422894 10.1016/j.toxlet.2009.04.026 1:CAS:528:DC%2BD1MXnsFygsL0%3D
35. M Prigol S Pinton R Schumacher CW Nogueira G Zeni 2010 Convulsant action of diphenyl diselenide in rat pups: measurement and correlation with plasma, liver and brain levels of compound Arch Toxicol 84 373 378 20047088 10.1007/s00204-009-0507-y 1:CAS:528:DC%2BC3cXisVWnsg%3D%3D